News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
CSL Gets FDA Close Out Letter
August 24, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CSL Group has resolved the manufacturing problems it faced over the last 12 months to finish fiscal 2012 with higher revenue and profits.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Asia
Australia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
April 1, 2026
·
1 min read
·
Heather McKenzie
Funding
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
April 1, 2026
·
2 min read
·
Tristan Manalac
Company closure
IO Shuts Down Following Regulatory Roadblocks
April 1, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Novo Sheds 400 at Embattled Manufacturing Site
April 1, 2026
·
43 min read
·
BioSpace Editorial Staff
